IJMS | Free Full-Text | Tumors of the Nose and Paranasal Sinuses: Promoting Factors and Molecular Mechanisms—A Systematic Review
Programmed Death-Ligand 1 and Programmed Death-Ligand 2 mRNAs Measured Using Closed-System Quantitative Real-Time Polymerase Chain Reaction Are Associated With Outcome and High Negative Predictive Value in Immunotherapy-Treated NSCLC - ScienceDirect
Fragment-based screening of programmed death ligand 1 (PD-L1) - ScienceDirect
Cancers | Free Full-Text | Long Non-Coding RNAs: Tools for Understanding and Targeting Cancer Pathways
Fragment-based screening of programmed death ligand 1 (PD-L1) - ScienceDirect
IJMS | Free Full-Text | Programmed Death Ligand 1 Indicates Pre-Existing Adaptive Immune Response by Tumor-Infiltrating CD8+ T Cells in Non-Small Cell Lung Cancer
Structural insights and binding analysis for determining the molecular bases for programmed cell death protein ligand-1 inhibition - MedChemComm (RSC Publishing)
IJMS | Free Full-Text | Programmed Death Ligand 1 Indicates Pre-Existing Adaptive Immune Response by Tumor-Infiltrating CD8+ T Cells in Non-Small Cell Lung Cancer
Programmed death-1 receptor (PD-1) and PD-ligand-1 (PD-L1) expression in non-small cell lung cancer and the immune-suppressive effect of anaerobic glycolysis | SpringerLink
Exploring the Effect of Halogenation in a Series of Potent and Selective A2B Adenosine Receptor Antagonists | Journal of Medicinal Chemistry
Programmed death‑ligand 1 positivity can predict improved survival and a lower risk of brain metastasis in patients with resectable small cell lung cancer
Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action | Immunotherapy
Programmed Death-Ligand 1 and Programmed Death-Ligand 2 mRNAs Measured Using Closed-System Quantitative Real-Time Polymerase Chain Reaction Are Associated With Outcome and High Negative Predictive Value in Immunotherapy-Treated NSCLC - ScienceDirect
Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action | Immunotherapy
Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC - ScienceDirect
Mechanism of anti-programmed death 1 (PD-1) receptor and... | Download Scientific Diagram
IJMS | Free Full-Text | Programmed Death Ligand 1 Indicates Pre-Existing Adaptive Immune Response by Tumor-Infiltrating CD8+ T Cells in Non-Small Cell Lung Cancer
PLGA Nanoparticles Codelivering siRNAs against Programmed Cell Death Protein-1 and Its Ligand Gene for Suppression of Colon Tumor Growth.,Molecular Pharmaceutics - X-MOL
Reconstruction of the Fas-Based Death-Inducing Signaling Complex (DISC) Using a Protein–Protein Docking Meta-Approach | Journal of Chemical Information and Modeling
PD-1/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model | Nature Communications
Fragment-based screening of programmed death ligand 1 (PD-L1) - ScienceDirect
Mechanisms for intratumoral programmed cell death ligand-1 (PD-L1)... | Download Scientific Diagram
Discordance of PD-L1 status between primary and metastatic breast cancer: A systematic review and meta-analysis - Cancer Treatment Reviews